Found: 7
Select item for more details and to access through your institution.
Nanobodies raised against monomeric α-synuclein inhibit fibril formation and destabilize toxic oligomeric species.
- Published in:
- BMC Biology, 2017, v. 15, p. 1, doi. 10.1186/s12915-017-0390-6
- By:
- Publication type:
- Article
Understanding and predicting disease relationships through similarity fusion.
- Published in:
- Bioinformatics, 2019, v. 35, n. 7, p. 1213, doi. 10.1093/bioinformatics/bty754
- By:
- Publication type:
- Article
The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases - recommendations of the IRDiRC Data Mining and Repurposing Task Force.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Preconditioning of Microglia by α-Synuclein Strongly Affects the Response Induced by Toll-like Receptor (TLR) Stimulation.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0079160
- By:
- Publication type:
- Article
Exploring the role of post‐translational modifications in regulating α‐synuclein interactions by studying the effects of phosphorylation on nanobody binding.
- Published in:
- Protein Science: A Publication of the Protein Society, 2018, v. 27, n. 7, p. 1262, doi. 10.1002/pro.3412
- By:
- Publication type:
- Article
A novel combination treatment for fragile X syndrome predicted using computational methods.
- Published in:
- Brain Communications, 2024, v. 6, n. 1, p. 1, doi. 10.1093/braincomms/fcad353
- By:
- Publication type:
- Article
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
- Published in:
- Human Molecular Genetics, 2018, v. 27, n. 12, p. 2052, doi. 10.1093/hmg/ddy108
- By:
- Publication type:
- Article